Literature DB >> 19960304

Preface: evidence-based practice guideline for the treatment of chronic kidney disease.

Sei Sasaki.   

Abstract

Entities:  

Mesh：

Year:  2009        PMID： 19960304     DOI： 10.1007/s10157-009-0235-x

Source DB:  PubMed          Journal:  Clin Exp Nephrol        ISSN： 1342-1751            Impact factor:   2.801


× No keyword cloud information.
  3 in total

1.  Utilization of glucagon-like peptide-1 receptor agonists and changes in clinical characteristics in patients with type 2 diabetes by chronic kidney disease stage in Japan: A descriptive observational study using a nationwide electronic medical records database.

Authors:  Naoki Hirose; Naoto Tsujimoto; Taeko Katayose; Rina Chin
Journal:  Diabetes Obes Metab       Date:  2021-12-05       Impact factor: 6.408

2.  Metallothionein MT2A A-5G Polymorphism as a Risk Factor for Chronic Kidney Disease and Diabetes: Cross-Sectional and Cohort Studies.

Authors:  Yuta Hattori; Mariko Naito; Masahiko Satoh; Masahiro Nakatochi; Hisao Naito; Masashi Kato; Sahoko Takagi; Takashi Matsunaga; Toshio Seiki; Tae Sasakabe; Shino Suma; Sayo Kawai; Rieko Okada; Asahi Hishida; Nobuyuki Hamajima; Kenji Wakai
Journal:  Toxicol Sci       Date:  2016-04-27       Impact factor: 4.849

3.  Dietary casein, egg albumin, and branched-chain amino acids attenuate phosphate-induced renal tubulointerstitial injury in rats.

Authors:  Karin Shimada; Isao Matsui; Kazunori Inoue; Ayumi Matsumoto; Seiichi Yasuda; Yusuke Katsuma; Yusuke Sakaguchi; Minoru Tanaka; Ken Sugimoto; Jun-Ya Kaimori; Yoshitsugu Takabatake; Yoshitaka Isaka
Journal:  Sci Rep       Date:  2020-11-04       Impact factor: 4.379
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.